Adage Capital Partners Gp, L.L.C. Charles River Laboratories International, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$56.4 Billion
Q2 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 45,000 shares of CRL stock, worth $7.65 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

45,000

Holding current value

$7.65 Million

% of portfolio

0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$99.75 - $151.89 $4.49 Million - $6.84 Million	45,000 New	45,000 $6.83 Million
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $9.27 Million - $12.1 Million	-44,914 Reduced 51.52%	42,269 $8.73 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $13.6 Million - $18.3 Million	-66,872 Reduced 43.41%	87,183 $23.6 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $7.3 Million - $10.6 Million	44,342 Added 40.42%	154,055 $36.4 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $19.2 Million - $21.4 Million	98,565 Added 884.15%	109,713 $21.5 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $614,142 - $702,865	3,343 Added 42.83%	11,148 $2.34 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $8.44 Million - $11.4 Million	-43,995 Reduced 84.93%	7,805 $1.58 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $10.2 Million - $13 Million	51,800 New	51,800 $11.3 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $8.21 Million - $12.2 Million	40,200 Added 316.54%	52,900 $11.3 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $10.5 Million - $14.9 Million	-41,100 Reduced 76.39%	12,700 $3.61 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $281,104 - $358,944	-800 Reduced 1.47%	53,800 $20.3 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $298,112 - $366,640	-800 Reduced 1.44%	54,600 $22.5 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $16.3 Million - $20.6 Million	55,400 New	55,400 $20.5 Million
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $14.7 Million - $17.3 Million	-150,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $5.02 Million - $5.9 Million	50,000 Added 50.0%	150,000 $16.4 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $9.67 Million - $10.9 Million	100,000	100,000 $10.8 Million

Others Institutions Holding CRL

# of Institutions

615

Shares Held

52.7M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.65B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Charles River Laboratories International, Inc. Transaction History